Drug Type Small molecule drug |
Synonyms Butramin |
Target |
Action inhibitors |
Mechanism Dopamine reuptake inhibitors, NET inhibitors(Norepinephrine transporter inhibitors), Serotonin reuptake inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (27 Feb 2008), |
Regulation- |
Molecular FormulaC17H26ClN |
InChIKeyUNAANXDKBXWMLN-UHFFFAOYSA-N |
CAS Registry106650-56-0 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D08513 | Sibutramine sulfate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Obesity | South Korea | 27 Feb 2008 |